Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1951 4
1952 1
1954 2
1955 1
1958 1
1959 1
1961 1
1962 2
1963 4
1964 4
1965 6
1966 6
1968 4
1969 3
1970 4
1971 1
1972 5
1973 4
1974 5
1975 6
1976 8
1977 7
1978 4
1979 14
1980 9
1981 5
1982 5
1983 7
1984 7
1985 7
1986 10
1987 10
1988 8
1989 5
1990 7
1991 12
1992 11
1993 14
1994 16
1995 21
1996 24
1997 18
1998 23
1999 29
2000 35
2001 70
2002 60
2003 64
2004 64
2005 94
2006 111
2007 92
2008 128
2009 120
2010 152
2011 196
2012 213
2013 196
2014 255
2015 313
2016 295
2017 327
2018 361
2019 410
2020 467
2021 514
2022 575
2023 613
2024 263

Text availability

Article attribute

Article type

Publication date

Search Results

5,679 results

Results by year

Filters applied: . Clear all
Page 1
Adebrelimab or placebo plus carboplatin and etoposide as first-line treatment for extensive-stage small-cell lung cancer (CAPSTONE-1): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Wang J, Zhou C, Yao W, Wang Q, Min X, Chen G, Xu X, Li X, Xu F, Fang Y, Yang R, Yu G, Gong Y, Zhao J, Fan Y, Liu Q, Cao L, Yao Y, Liu Y, Li X, Wu J, He Z, Lu K, Jiang L, Hu C, Zhao W, Zhang B, Shi W, Zhang X, Cheng Y; CAPSTONE-1 Study Group. Wang J, et al. Among authors: lu k. Lancet Oncol. 2022 Jun;23(6):739-747. doi: 10.1016/S1470-2045(22)00224-8. Epub 2022 May 13. Lancet Oncol. 2022. PMID: 35576956 Clinical Trial.
Methionine restriction-induced sulfur deficiency impairs antitumour immunity partially through gut microbiota.
Ji M, Xu X, Xu Q, Hsiao YC, Martin C, Ukraintseva S, Popov V, Arbeev KG, Randall TA, Wu X, Garcia-Peterson LM, Liu J, Xu X, Andrea Azcarate-Peril M, Wan Y, Yashin AI, Anantharaman K, Lu K, Li JL, Shats I, Li X. Ji M, et al. Among authors: lu k. Nat Metab. 2023 Sep;5(9):1526-1543. doi: 10.1038/s42255-023-00854-3. Epub 2023 Aug 3. Nat Metab. 2023. PMID: 37537369 Free PMC article.
Atogepant for the preventive treatment of chronic migraine (PROGRESS): a randomised, double-blind, placebo-controlled, phase 3 trial.
Pozo-Rosich P, Ailani J, Ashina M, Goadsby PJ, Lipton RB, Reuter U, Guo H, Schwefel B, Lu K, Boinpally R, Miceli R, De Abreu Ferreira R, McCusker E, Yu SY, Severt L, Finnegan M, Trugman JM. Pozo-Rosich P, et al. Among authors: lu k. Lancet. 2023 Sep 2;402(10404):775-785. doi: 10.1016/S0140-6736(23)01049-8. Epub 2023 Jul 26. Lancet. 2023. PMID: 37516125 Clinical Trial.
Fe65-engineered neuronal exosomes encapsulating corynoxine-B ameliorate cognition and pathology of Alzheimer's disease.
Iyaswamy A, Thakur A, Guan XJ, Krishnamoorthi S, Fung TY, Lu K, Gaurav I, Yang Z, Su CF, Lau KF, Zhang K, Ng RC, Lian Q, Cheung KH, Ye K, Chen HJ, Li M. Iyaswamy A, et al. Among authors: lu k. Signal Transduct Target Ther. 2023 Oct 23;8(1):404. doi: 10.1038/s41392-023-01657-4. Signal Transduct Target Ther. 2023. PMID: 37867176 Free PMC article.
ALS-linked C9orf72-SMCR8 complex is a negative regulator of primary ciliogenesis.
Tang D, Zheng K, Zhu J, Jin X, Bao H, Jiang L, Li H, Wang Y, Lu Y, Liu J, Liu H, Tang C, Feng S, Dong X, Xu L, Yin Y, Dang S, Wei X, Ren H, Dong B, Dai L, Cheng W, Wan M, Li Z, Chen J, Li H, Kong E, Wang K, Lu K, Qi S. Tang D, et al. Among authors: lu k. Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2220496120. doi: 10.1073/pnas.2220496120. Epub 2023 Dec 8. Proc Natl Acad Sci U S A. 2023. PMID: 38064514
5,679 results